Home Tags GSK

Tag: GSK

Emma Walmsley of GlaxoSmithKline poses in this undated photograph released in London.

Pharma giant GSK just made a $5.1 billion bet on a cancer-drug maker

The pharma giant GlaxoSmithKline just acquired the cancer-drug maker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline.
A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014.

A drugmaker’s popular new shingles vaccine faces shortages due to high demand

Shingrix, a new shingles vaccine by drugmaker GlaxoSmithKline, was approved for use by the FDA in 2017. It is currently experiencing shortages due to high demands. Shingrix is significantly more effective than Zostavax, which was the shingles vaccine that has been used since 2006.
23andMe CEO Anne Wojcicki explained why the company is working with GSK to develop drugs.

Here’s the email 23andMe sent its customers after GSK bought a $300 million stake in the company

"23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen," 23andMe's CEO wrote. "By working with GSK, we believe we will accelerate the development of breakthroughs."

DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out.

Genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.

Why pharma giant GSK just made a $300 million bet on 23andMe’s approach to finding new medicines

The consumer genetics company 23andMe is teaming up with the UK drug giant GlaxoSmithKline to develop new drugs. As part of the four-year collaboration, GSK is committing $300 million to 23andMe and is working on an experimental drug to treat Parkinson's disease.
FDA Commissioner Scott Gottlieb

The FDA just called out drugmakers that are ‘gaming’ the system to delay competition

The Food and Drug Administration, oversees among other things drug approvals. On Thursday, the agency published a list of 52 drugs it deemed are facing delays to getting generic versions because of "gaming" happening on the part of brand drugmakers.

A new pill to treat HIV just got approved — and it could shake up a $22 billion market

The treatment made by Gilead combines three drugs into one daily pill:  bictegravir, emtricitabine and tenofovir alafenamide.
Emma Walmsley of GlaxoSmithKline poses in this undated photograph released in London.

The first female big pharma CEO had the perfect response to a question about women in leadership

GlaxoSmithKline CEO Emma Walmsley made history in 2017, when she became the first woman to head up a major pharmaceutical company.

DIGITAL HEALTH BRIEFING: Viant, GSK partner for blockchain in pharmaceuticals — CMS moves to increase the use of digital health solutions &...

Blockchain startup Viant announced a new collaboration with pharmaceutical giant GlaxoSmithKline (GSK), Microsoft, and others to develop supply chain solutions.